Chemidex Generics Limited v The Commissioners for HMRC

Decision date: 19 December 2024

Neutral citation: [2024] UKFTT 1146 (TC)

Overall AI summary confidence: high

AI Notice: Any short overview, ratio decidendi summary or obiter dicta summary shown on this page is AI-generated, provided only to help users assess potential relevance more quickly, and may be wholly inaccurate. No liability is accepted for the accuracy of any such summary, regardless of any AI confidence rating shown. Users should check the underlying decision and obtain appropriate legal advice rather than relying on any summary.

Short overview

This short overview is intended to summarise the case, issues and outcome so far as they are supported by the judgment.

AI confidence in this short overview: high

This appeal concerned the market value as at 27 March 2013 of intangible "Product Assets" sold to Chemidex Generics Limited (CGL) and whether CGL's ten‑year amortisation in its 2013 accounts complied with UK GAAP. The Tribunal found the market value of the Product Assets was £40 million and that, despite some misclassification and disclosure failures, a ten‑year amortisation period lay within an acceptable UK GAAP range. The appeal was allowed.

Ratio decidendi

This summary is intended to identify the ratio decidendi, meaning the legal reasons for deciding and the binding part of the decision.

AI confidence in this ratio decidendi summary: medium

Where a purchaser acquires intangibles that are exploited under terminable exploitation agreements, market value for tax purposes may reflect the purchaser's contractual rights (including termination/reversion) and the hypothetical buyer's highest and best use; and an amortisation period that falls within a justifiable range of useful economic life, having regard to uncertainty and relevant UK GAAP standards, can be compliant even if it is toward the lower end of possible spans.

Obiter dicta

This summary is intended to identify obiter dicta, meaning observations made by the way that were not necessary to deciding the case and are not binding.

AI confidence in this obiter dicta summary: medium

The Tribunal indicated it may properly give significant weight to seller‑side contemporaneous valuations and commercial reality where the evidential picture supports them; that valuation expert evidence is weakened where experts lack parity of access to management information; and that the contractual structure and replaceability of the exploiting entity are material considerations in allocating value between intangible assets and operational arrangements.